The Leading NHP Partner for Advancing Preclinical Research with Precision and Integrity
At Envol Biomedical, we provide full-spectrum preclinical research solutions built on scientific precision, ethical integrity, and operational scale. As the largest provider of nonhuman primate (NHP) subjects in North America, Envol supports sponsors with unparalleled access to translational models, integrated laboratory services, and advanced surgical and imaging capabilities—all under one roof.
Our AAALAC-accredited, USDA-registered, and OLAW-compliant facilities ensure every study meets the highest standards of animal welfare and regulatory excellence. From discovery through IND-enabling development, our cross-functional teams deliver reliable, submission-ready data that accelerate timelines and reduce risk. Whether advancing a small molecule, biologic, or gene therapy, Envol provides the scientific partnership and infrastructure needed to turn breakthrough ideas into meaningful outcomes.


Recent Blogs
Odin Bioscience and Envol Biomedical combine to offer Biological Matrices and Premier NHP Research-Come see us at SOT 2026
As the global toxicology community gathers in San Diego for the Society of Toxicology (SOT)...The Study Director Advantage: How Envol Biomedical Builds Scientific Leadership Into Every Study
In preclinical drug development, success is rarely determined by infrastructure alone. While facilities, equipment, and...Vertical Integration and Supply Chain Stability: Why Sponsors Are Turning to Fully Integrated Research Partners Like Envol Biomedical
In today’s drug development landscape, timelines are tighter, regulatory expectations are higher, and sponsors face...Capabilities & Services
Envol Biomedical provides translational pharmacology services using nonhuman primate (NHP) models to generate precise, actionable data that advance drug development from discovery through IND-enabling studies.
Envol Biomedical conducts advanced pharmacokinetic (PK) studies in nonhuman primates (NHPs), delivering precise ADME data through integrated surgical, analytical, and digital modeling expertise.
Envol Biomedical delivers GLP and non-GLP toxicology programs in nonhuman primates (NHPs), combining regulatory rigor, surgical expertise, and real-time data reporting to accelerate IND readiness.
Envol Biomedical integrates advanced imaging technologies across preclinical programs to enhance surgical precision, disease modeling, and data interpretation in NHP studies.
Envol Biomedical’s in-house surgical team enables complex dosing, serial sampling, and targeted delivery in NHP studies with clinical-grade precision and cross-functional coordination.
Envol Biomedical’s Core Laboratory Services provide comprehensive analytical, bioanalytical, and molecular assay support that powers every pharmacology, PK, and toxicology study with speed, precision, and regulatory-grade data integrity.
Envol maintains in-house breeding and colony management programs that ensure animal health, genetic integrity, and regulatory compliance; providing consistent, study-ready models for pharmacology, toxicology, and surgical research.
Envol Biomedical conducts indication- focused NHP studies across CNS, ocular, and respiratory therapeutic areas, combining surgical precision, validated models, and regulatory insight to accelerate translational drug development.
Envol Biomedical provides high-quality biological matrices—blood, tissues, cells, and biofluids—sourced through ODIN Bioscience and integrated into its GLP laboratory workflows for reliable, reproducible research outcomes.


